Dual protease activated peptides for specific targeting

用于特异性靶向的双蛋白酶激活肽

基本信息

项目摘要

Project Summary/Abstract Here we develop a platform for protease-activated peptide prodrugs. We initially focus the effort on antimicrobial peptides (AMP), which have a broad spectrum of cell-penetrating, antimicrobial and cytotoxic activities. However, they have multiple limitations, including off-target cytotoxicity and proteolytic instability. To circumvent these unwanted effects, linear protease-activated prodrugs have been employed. Although effective at enhancing the activity of the active payload, it does not adequately address the side effects stated above. To mitigate the side effects of the traditional protease-activated prodrug approach, the proposed research strategy herein seeks to design a branched protease-activated prodrug by coupling a cleavable linker to the sidechains of amino acid residue that significantly impacts antimicrobial peptide activity. As a proof-of-concept, bombolitin (an AMP that is cytotoxic to mammalian cells) will be used as the payload, masked with caspase-3 and fibroblast activation protein (cancer biomarkers) substrate-specific linkers. By modifying the sidechains of Lys, Ser, Thr, and Tyr with these linkers, we hypothesize that the physicochemical properties of bombolitin will be significantly altered, thus reducing peptide-membrane interaction until activation. In this research, we propose to 1) design and synthesize single and double-branched protease-activated prodrugs cleaved in the presence of either caspase-3 and/or fibroblast activation protein to yield the active peptide, 2) confirm caspase-3 and fibroblast activation protein cleavage of linker from prodrugs by performing in vitro enzymatic assays and biophysical analysis, and 3) perform cell-based assays to validate prodrug cleavage, target specificity, activity enhancement, and reduction of off-target effects.
项目总结/摘要 在这里,我们开发了一个蛋白酶激活肽前药的平台。我们首先将精力集中在 抗菌肽(AMP)具有广谱的细胞穿透性、抗菌性和细胞毒性, 活动然而,它们具有多种局限性,包括脱靶细胞毒性和蛋白水解不稳定性。到 为了避免这些不需要的作用,已经使用了线性蛋白酶活化的前药。虽然有效 在增强有源有效载荷的活性方面,它没有充分解决上述副作用。到 减轻传统的蛋白酶激活前药方法的副作用,提出了研究策略, 本文试图通过将可裂解的接头偶联到侧链上来设计支化的蛋白酶活化的前药 显著影响抗菌肽活性的氨基酸残基。作为概念验证, (an对哺乳动物细胞具有细胞毒性的AMP)将用作有效载荷,用半胱天冬酶-3和成纤维细胞掩蔽 活化蛋白(癌症生物标志物)底物特异性接头。通过修饰Lys、Ser、Thr的侧链, 和Tyr与这些接头,我们假设,bombolitin的物理化学性质将显着 改变,从而减少肽-膜相互作用直到活化。在本研究中,我们建议1)设计 并合成单和双分支蛋白酶激活的前药, 半胱天冬酶-3和/或成纤维细胞活化蛋白,以产生活性肽,2)证实半胱天冬酶-3和成纤维细胞活化蛋白, 通过进行体外酶促测定和生物物理测定从前药上活化蛋白质裂解接头 分析,和3)进行基于细胞的测定以验证前药切割、靶特异性、活性增强, 和减少脱靶效应。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ethel Naa Odey Tackie-Yarboi其他文献

Ethel Naa Odey Tackie-Yarboi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
  • 批准号:
    BB/Y006380/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.91万
  • 项目类别:
    Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
  • 批准号:
    24K17112
  • 财政年份:
    2024
  • 资助金额:
    $ 6.91万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
  • 批准号:
    23K04668
  • 财政年份:
    2023
  • 资助金额:
    $ 6.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
  • 批准号:
    23K06918
  • 财政年份:
    2023
  • 资助金额:
    $ 6.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
  • 批准号:
    23K05758
  • 财政年份:
    2023
  • 资助金额:
    $ 6.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
  • 批准号:
    2888395
  • 财政年份:
    2023
  • 资助金额:
    $ 6.91万
  • 项目类别:
    Studentship
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
  • 批准号:
    2300890
  • 财政年份:
    2023
  • 资助金额:
    $ 6.91万
  • 项目类别:
    Continuing Grant
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
  • 批准号:
    10761044
  • 财政年份:
    2023
  • 资助金额:
    $ 6.91万
  • 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
  • 批准号:
    10728925
  • 财政年份:
    2023
  • 资助金额:
    $ 6.91万
  • 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
  • 批准号:
    10757309
  • 财政年份:
    2023
  • 资助金额:
    $ 6.91万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了